Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-25

FDA Approved: FEBUXOSTAT — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application for febuxostat submitted by Aurobindo Pharma Limited, authorizing marketing of a generic febuxostat product in the United …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)